Topic: How To Invest

What is your opinion about ResMed Inc.? Thanks.

Article Excerpt

ResMed, $31.70, symbol RMD on New York (Shares outstanding: 156.7 million; Market cap: $5.0 billion; www.resmed.com), develops, makes and distributes medical equipment for treating, diagnosing and managing respiratory disorders, such as sleep-disordered breathing (SDB), which includes obstructive sleep apnea and other respiratory conditions that occur during sleep. ResMed markets its products in over 70 countries through wholly owned subsidiaries and independent distributors. The company’s earnings rose 10.0% in the three months ended June 30, 2011, to a record $58.5 million, or $0.38 a share. A year earlier, it earned $53.2 million, or $0.35 a share. Sales rose 17.3%, to a record $341.9 million from $291.6 million. The company holds cash of $735.3 million, or $4.69 a share. Its long-term debt of $100 million is just 2% of its market cap. ResMed continues to make small acquisitions that add to its product lineup. In July 2011, it bought BiancaMed, an Ireland-based medical-technology company that specializes in making devices that monitor sleep and…